Viewing Study NCT07357194


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-31 @ 1:28 PM
Study NCT ID: NCT07357194
Status: COMPLETED
Last Update Posted: 2026-01-21
First Post: 2026-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Renal Rehabilitation Among Patients With Kidney Failure
Sponsor: Cairo University
Organization:

Study Overview

Official Title: Barriers to Renal Rehabilitation Among Patients With Kidney Failure in Governmental Hospitals in Cairo: A Cross-Sectional Study
Status: COMPLETED
Status Verified Date: 2026-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary purpose of this study is to identify and analyze the barriers to renal rehabilitation among patients diagnosed with kidney failure in Cairo
Detailed Description: This study is a cross-sectional design aimed at identifying the barriers to renal rehabilitation among patients diagnosed with kidney failure in governemtnal hospitals in Cairo.

The sample size for this study was determined using G\*POWER statistical software (version 3.1.9.2; Franz Faul, Universitat Kiel, Germany) and was based on a previous study by (Bossola et al., 2014). which reported a prevalence of 38.1%. The required sample size calculated for this study is N=155, with calculations made using a significance level (α) of 0.05 and a statistical power of 80%. This sample size is deemed appropriate for achieving the study's objectives and ensuring statistically significant results.

155 patients suffering from kidney failure will participate in the study. They will be selected randomly from the different governmental hospitals centers in Cairo, Informed consent Freely and voluntarily consent to participate in this research study (Effect of pelvic floor down-training exercise on females with idiopathic overactive bladder) under the supervision and direction of the researcher/ Merna Mabrouk A thorough description of the study procedures has been explained to me, and I understand that I may withdraw my consent and discontinue participation in this study research at any time without prejudice to me.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: